Edmond de Rothschild Investment Partners closes BioDiscovery 4
Edmond de Rothschild Investment Partners has closed its BioDiscovery 4 venture capital fund for European life science companies after raising 192 million euros (US$ 250 million). Through BioDiscovery 4, Edmond de Rothschild Investment Partners will lead investments in 15 to 20 life sciences companies across all stages of development.
4 November 2013•3 mins read
